Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma PopulationWaleed Alduaij, David W. Scott, Pedro Farinha et al.|Blood|2022Cited by 89
Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patternsKostiantyn Dreval, Ryan D. Morin, Laura K. Hilton et al.|Blood|2023Cited by 53
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K. Hilton, David W. Scott, Henry S. Ngu et al.|Journal of Clinical Oncology|2023Cited by 50
Motive and opportunity: <i>MYC</i> rearrangements in high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> rearrangements (an LLMPP study)Laura K. Hilton, David W. Scott, Brett Collinge et al.|Blood|2024Cited by 35
CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECTBrett Collinge, David W. Scott, Laura K. Hilton et al.|Hematological Oncology|2021Cited by 20